arrow_back Trending Legislation
Share share

Rare Disease Day: Raising Awareness and Supporting Research

The U.S. Senate designated February 28, 2022, as Rare Disease Day. This aims to increase public awareness of these conditions, which affect millions of Americans, and emphasize the need for further research and effective treatments. Citizens with rare diseases and their families can expect greater support in accessing diagnosis and treatment.
Key points
The designation of Rare Disease Day aims to highlight the challenges faced by individuals with these conditions, including difficulties in diagnosis and limited access to treatment.
It emphasizes the importance of accurate and early diagnosis and supporting national and global efforts to develop effective treatments and diagnostics.
The resolution acknowledges progress in rare disease research, stemming from previous acts like the Orphan Drug Act, offering hope for new therapies for patients.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Adopted
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution designating February 28, 2022, as "Rare Disease Day".
Print number: SRES 523
Sponsor: Sen. Brown, Sherrod [D-OH]
Process start date: 2022-02-17
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Rare Disease Day: Raising Awareness and Supporting Research

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 523.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-02-17.

What are the main provisions?

Key points include:

  • The designation of Rare Disease Day aims to highlight the challenges faced by individuals with these conditions, including difficulties in diagnosis and limited access to treatment.
  • It emphasizes the importance of accurate and early diagnosis and supporting national and global efforts to develop effective treatments and diagnostics.
  • The resolution acknowledges progress in rare disease research, stemming from previous acts like the Orphan Drug Act, offering hope for new therapies for patients.

What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Brown, Sherrod [D-OH].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S800; text: CR S793-794)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of SRES 523

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health